Suggestions
Arnaub Chatterjee
President and GM - Life Sciences, Ecosystem, Public Sector, Datavant
Arnaub Chatterjee
Arnaub Chatterjee is the Chief Product and Solutions Officer at TriNetX and a Senior Advisor at The Carlyle Group. He is also a Member of the Board of Directors at MJH Life Sciences, a Teaching Associate at Harvard Medical School, and a Lecturer at Cornell University.1
Previously, Chatterjee served as the Senior Vice President of Medidata AI at Medidata Solutions, where he led the data science company's efforts in building software and data products for clinical trial development, operations, imaging, and launch.1 He was also an Associate Partner and Senior Expert in the Pharmaceutical and Medical Products group at McKinsey & Company.1
Chatterjee has held several roles at Merck, including Director of the Center for Observational and Real World Evidence and Associate Director of Business Development and Strategic Partnerships.1 He has also served in the Obama Administration as an advisor to former Chief Technology Officers at the U.S. Department of Health and Human Services.1
Chatterjee holds graduate degrees in health administration (MHA) and public administration (MPA) from Cornell University and an undergraduate degree from the University of Michigan.2 He is a native of Minnesota but currently resides in Boston with his family.2
Highlights
Historically, clinical trial recruitment has excluded representative, real-world cohorts, magnifying the need to fully encompass the diversity of real-world patient populations in today’s clinical trials. In this innovative study, researchers at Jefferson Health (Thomas Jefferson University Hospital) provide a view into the TriNetX Diversity Lens, exploring ways to reduce demographic disparities while building diverse patient cohorts for clinical trial recruitment. Read now at https://rb.gy/nzmcq! #DEI #RealWorldData #ClinicalTrials
Looking forward to speaking at Cornell Tech at the Cornell University Biotech and Pharmaceutical Management Summit. Wonderful lineup of speakers (Saif S. Rathore of Boston Consulting Group (BCG) and I will be covering the State of the Biotech Industry) and timely topics such as #diversity in clinical trials, value and access, Sean Nicholson and David Artz, MD, MBA discussing the evolution of pharma policy and Joydeep Ganguly of Gilead Sciences sharing his insights on emerging and disruptive trends. cc TriNetX Cornell Sloan Program in Health Administration
https://lnkd.in/eKguZ4vv
